Active Not Recruiting NA INTERVENTIONAL 2-arm
NCT07100743
Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE) (ProbE)
A Randomised Double-blind Placebo-Controlled Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)
Sponsor: B-Crobes Laboratory Sdn. Bhd
Conditions
Epilepsies Refractory
Interventions
Placebo Probiotic Agent
Updated 1 time since 2025 Last updated: Jul 27, 2025 Started: Apr 3, 2023 Primary completion: Mar 2, 2026 Completion: Mar 2, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Epilepsies Refractory, this trial is ongoing. The trial is conducted by B-Crobes Laboratory Sdn. Bhd and has accumulated 1 data snapshot since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Active Not Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- B-Crobes Laboratory Sdn. Bhd
- National University of Malaysia
Data source: National University of Malaysia
For direct contact, visit the study record on ClinicalTrials.gov .